Beijing, China

Bang Fu

This inventor holds 1 USPTO granted patent and 9 published patent applications. Top assignee: Betta Pharmaceuticals Co., Ltd.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bang Fu. Retrieved from https://idiyas.com/inventor/bang-fu-fj5z0km2

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Bang Fu - Innovator in Immunomodulation

Introduction

Bang Fu is a prominent inventor based in Beijing, China. He has made significant contributions to the field of immunology through his innovative research and development of new compounds. His work focuses on creating effective treatments for various diseases, including cancer and infections.

Latest Patents

Bang Fu holds a patent for "Immunomodulators, compositions and methods thereof." This patent includes compounds of Formula (I) and outlines methods for using these compounds as immunomodulators. The pharmaceutical compositions derived from his research are designed to treat, prevent, or ameliorate diseases and disorders such as cancer or infections. He has 1 patent to his name.

Career Highlights

Bang Fu is associated with Betta Pharmaceuticals Co., Ltd., where he applies his expertise in immunology to develop groundbreaking therapies. His work has been instrumental in advancing the understanding of immunomodulation and its applications in medicine.

Collaborations

He collaborates with notable colleagues, including Yiqian Wang and Yao Zhang, to further enhance the impact of his research and innovations in the pharmaceutical industry.

Conclusion

Bang Fu's contributions to immunology and his innovative patent work exemplify the importance of research in developing new treatments for serious health conditions. His dedication to advancing medical science continues to inspire future innovations in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…